This is the second in a two-part series on the opportunities in markets outside of North America. Read part one here. While ...

Trump's choice for DEA administrator has publicly opposed marijuana legalization, despite the president's campaign pledge to ...

The founders of cannabis edibles maker Hometown Hero are betting on luxury CBD skincare with their acquisition of Prima.

Cybin pushes forward with Phase 3 depression trials after posting a narrower loss, while securing a $100M funding program.

The success of Epidiolex prompted several companies to attempt to create generic versions. Jazz Pharmaceuticals plc (NASDAQ: ...

The Canadian cannabis producer missed revenue expectations but posted stronger margins as international sales surge.

Many businesses are grappling with declining wholesale prices, compliance costs and limited access to banking.

Glass House attributed the solid results to cost cutting and lower production costs, along with increased same-store sales.

The U.S. cannabis market continues to be the largest in the world, but uncertainty around legalization and illicit market ...

The settlement could finally close the chapter on a five-year-old lawsuit alleging Tilray insiders secretly profited from ...

MediPharm will keep its Ontario cannabis facility after Kensana missed deal conditions; company pivots to international focus ...

The firm is betting big on harm-reduction technology, as the fentanyl crisis continues to drive demand for testing solutions.